Stockscreener 앱 받기
30.89
0.68%
0.21
시장 영업 전:
31.23
0.34
+1.10%
전일 마감가:
$30.68
열려 있는:
$30.58
하루 거래량:
1.22M
Relative Volume:
0.53
시가총액:
$3.59B
수익:
-
순이익/손실:
$-472.34M
주가수익비율:
-7.4507
EPS:
-4.1459
순현금흐름:
$-340.33M
1주 성능:
+2.05%
1개월 성능:
-9.81%
6개월 성능:
-9.84%
1년 성능:
+11.40%
1일 변동 폭
$30.29
$30.92
1주일 범위
$28.16
$30.92
52주 변동 폭
$22.96
$43.15
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Compare VKTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
30.89 | 3.56B | 0 | -472.34M | -340.33M | -4.1459 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-26 | 개시 | Wolfe Research | Peer Perform |
| 2025-10-29 | 개시 | Canaccord Genuity | Buy |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Prediction: These 2 Obesity Drug Stocks Could Double in 2026 - AOL.com
Is Viking Therapeutics (VKTX) Pricing In Too Much Optimism After Recent Share Price Swings? - simplywall.st
Don't Buy Viking Therapeutics Stock Until You Read This - AOL.com
A Look At Viking Therapeutics (VKTX) Valuation As Shares Show Mixed Recent Returns - Yahoo Finance
Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know. - The Motley Fool
Is Viking Therapeutics a Top Takeover Target? - The Motley Fool
Should New Phase 2 Oral VK2735 Weight-Loss Data Require Action From Viking Therapeutics (VKTX) Investors? - simplywall.st
Viking Therapeutics, Inc. Stock 12‑Month Price Target Raised to $95.4, Implies 209% Upside - TradingView
Viking Therapeutics Analyst Ratings and Price Targets | NASDAQ:VKTX - Benzinga
2 Stocks That Could Realistically Double by 2030 - The Motley Fool
VKTX Technical Analysis | Trend, Signals & Chart Patterns | VIKING THERAPEUTICS INC (NASDAQ:VKTX) - ChartMill
Viking Therapeutics faces timeline risk, but upside could be huge - MSN
Could Viking Therapeutics Be the Next Eli Lilly? - The Motley Fool
Viking Therapeutics to Participate at Upcoming Investor Conferences - PR Newswire
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party - The Globe and Mail
Three Biotechs That Are Top Takeover Targets - 24/7 Wall St.
Viking Therapeutics, Inc.Common Stock (NQ: VKTX - The Chronicle-Journal
VKTX stock slips premarket: A surprise weight loss drug beats Novo Nordisk in early animal tests - MSN
Viking Therapeutics, Inc. (VKTX) declines more than market: Some information for investors - MSN
The Bull Case For Viking Therapeutics (VKTX) Could Change Following New Oral VK2735 Obesity Data Release - Yahoo Finance
Avoiding Lag: Real-Time Signals in (VKTX) Movement - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
How New Oral VK2735 Obesity Data At Viking Therapeutics (VKTX) Has Changed Its Investment Story - simplywall.st
VKTX Q1 earnings miss on higher phase 3 development costs - MSN
Viking Therapeutics (VKTX) Valuation Revisited After New VK2735 Phase 2 Obesity Data Spurs Investor Interest - simplywall.st
Viking Therapeutics (VKTX) Reveals Promising Phase 2 Trial Resul - GuruFocus
Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTU - GuruFocus
Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 - PR Newswire
Patients on experimental obesity drug lost up to 26.6 lb in 13 weeks - Stock Titan
Earnings call transcript: Viking Therapeutics Q1 2026 sees widened net loss - Investing.com India
Earnings call transcript: Viking Therapeutics Q1 2026 sees widened net loss By Investing.com - Investing.com South Africa
75,475 Shares in Viking Therapeutics, Inc. $VKTX Bought by Channel Wealth LLC - MarketBeat
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.98%
1.33%
자본화:
|
볼륨(24시간):